A Case Study in GLP-1 Nervous System Support

A client in her early 50s from Northern Europe reduced systemic inflammation, measured by hs-CRP, from 5.6 to 1.4 mg/L in sixteen weeks. This was achieved through a targeted GLP-1 nervous system support protocol that also reversed a 4.1 kg loss of lean mass to a 1.2 kg gain.

The presenting state

The client had been on a GLP-1 agonist for nine months and had successfully reached her target weight. Despite this, she presented with persistent fatigue, flattened mood, and a feeling of being disconnected. Her high-sensitivity C-reactive protein (hs-CRP) level of 5.6 mg/L indicated moderate-grade systemic inflammation, a biological stressor that can contribute to a chronic state of nervous system defence, alternating between sympathetic activation and dorsal-vagal shutdown.

This pattern was compounded by significant muscle loss, a known risk of rapid weight loss without supportive intervention. The loss of metabolically active tissue can impair autonomic regulation. The client reported low interoception—an inability to clearly sense her body's internal cues. This experience is characteristic of prolonged states of autonomic dysregulation where the system remains in a protective, rather than socially engaged, state as detailed in polyvagal theory (Porges, 2022).

The protocol

The sixteen-week intervention was designed to complement her ongoing GLP-1 therapy by layering targeted metabolic and nervous-system support. The primary objectives were to defend and rebuild lean mass, improve vagal tone for greater autonomic resilience, and retune the gut-brain axis. GLP-1 agonists function in part by modulating these gut signals, and our protocol aimed to help her system adapt and integrate these new inputs for improved physiological function (He, 2022).

The protocol included:

• Protein Floor: A minimum daily intake of 1.6 grams of protein per kilogram of body weight to provide the necessary substrate for muscle protein synthesis and promote GLP-1 muscle preservation.
• Resistance Training: Three full-body resistance training sessions per week to provide the stimulus for muscle growth.
• Vagal Tone Practices: Five minutes of slow-paced breathing (4-second inhale, 6-second exhale) upon waking and before bed to gently guide the nervous system toward a ventral-vagal state of safety and connection.
• Post-Prandial Movement: A ten-minute slow walk after her main meal to support glucose management and activate the vagal tone GLP-1 pathway through gentle gut stimulation.
• Gut-Supportive Eating: Prioritising fibre diversity from over 30 different plant species per week, plus regular intake of fermented foods to support the gut microbiome and its communication with the brain.
• Nervous System Anchors: Specific somatic practices to help her navigate the changes in appetite cues and internal 'noise' as her gut signals GLP-1 adapted.
• Clinician Review: Quarterly review of her GLP-1 dosage with her prescribing physician to ensure it remained appropriate.

What changed

The most significant biomarker change was the 75% reduction in hs-CRP, from 5.6 to 1.4 mg/L. This moved the client from a moderate to a low-risk category for future cardiovascular events and demonstrated a substantial decrease in the chronic GLP-1 inflammation that was contributing to her fatigue. The client reported a parallel increase in sustained energy and mental clarity.

The protocol also successfully addressed her muscle loss. After losing 4.1 kg of lean mass during the initial months on the medication, she gained 1.2 kg of lean mass over our sixteen-week intervention. This improvement in body composition not only supported her metabolic health but also contributed to a felt sense of strength and physical resilience. Her mood became brighter and more stable, which she directly linked to feeling more present and capable in her body.

"I feel like I have the instruction manual for my body again. The weight loss was one part, but this feels like the complete picture."

TL;DR

A client in her 50s on a GLP-1 agonist experienced inflammation, fatigue, and muscle loss despite reaching her weight target. A sixteen-week GLP-1 nervous system support protocol focused on GLP-1 muscle preservation through resistance training and high protein intake, and improved vagal tone GLP-1 with breathing and movement. This approach reduced hs-CRP by 75%, reversed muscle loss, and improved mood by addressing underlying dysregulation in the nervous system and gut-brain axis, demonstrating a more holistic path to wellness on these medications.

Where to take this next

This case demonstrates that pharmacological tools like GLP-1 agonists operate within the complex environment of the human nervous system. Without concurrent support for autonomic regulation, gut health, and metabolic function, outcomes can remain incomplete, leaving individuals with unresolved symptoms. Integrating nervous system work with medical treatment provides a more robust and sustainable foundation for health.

To restore regulation, the system requires new, consistent reference points for safety. This begins with small practices that build interoceptive awareness and gently improve vagal tone. For individualised guidance on this, there are several pathways.

For a focused practice, explore our Vagus Nerve Support Anchor at /anchors. For individualised guidance, consider our 1:1 GLP-1 Support Coaching at /coaching. To begin exploring these concepts, start with our free 7-Day Nervous System Reset at /reset.